Zdrowie i gospodarka · 11/10/2018
FDA Renews Dermatologic and Ophthalmic Drugs Advisory Committee for 2 Years
The FDA is renewing the committee's charter for an additional 2 years, extending its term until October 7, 2020, at the request of the Commissioner of Food and Drugs.
Source: Federal Register — Food and Drug AdministrationOpen original release →